Business, Presentation and Recent Accounting Pronouncements (Details) |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jun. 06, 2023
USD ($)
|
Sep. 27, 2022
shares
|
Sep. 30, 2023
USD ($)
shares
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2023
USD ($)
shares
|
Sep. 30, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
shares
|
Sep. 26, 2022
shares
|
Sep. 23, 2022
shares
|
|
Subsidiary, Sale of Stock [Line Items] | |||||||||
Reverse stock split ratio | 0.025 | ||||||||
Common stock, shares authorized (in shares) | shares | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 | |||||
Number of fractional shares issued | shares | 0 | ||||||||
Common stock outstanding (in shares) | shares | 1,079,045 | 7,689,240 | 7,689,240 | 1,796,472 | 43,163,123 | ||||
Cash and cash equivalents | $ 5,400,498 | $ 5,400,498 | $ 5,964,556 | ||||||
Accumulated deficit | (144,708,249) | (144,708,249) | (134,462,959) | ||||||
Net proceeds | $ 5,600,000 | ||||||||
Equity line of credit (up to) | 9,600,000 | 9,600,000 | |||||||
In-Process R&D Impairment | 1,904,314 | $ 0 | 1,904,314 | $ 0 | |||||
Incurred expenses to related party vendor | 130,000 | ||||||||
In-Process R&D | |||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||
In-Process R&D | $ 8,695,100 | $ 10,600,000 | $ 8,695,100 | $ 10,600,000 | $ 10,599,414 | ||||
Common Stock | |||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||
Net proceeds | $ 5,600,000 |
X | ||||||||||
- Definition Equity Line Of Credit, Share Purchase Agreement, Sale Of Stock, Maximum Amount No definition available.
|
X | ||||||||||
- Definition Number of fractional shares issued as a result of reverse stock split. No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|